England Approves Animal-Human DNA Study
Posted on: Thursday, 17 January 2008, 12:00 CST
A government embryological watchdog in England approved the use of genetic hybrids for the use in embryonic stem cell research.
The Human Fertilization and Embryology Authority granted one-year licenses to King's College London and the University of Newcastle-upon-Tyne to inject human DNA into empty cow eggs to create cytoplasmic embryonic hybrids that are 99.9 percent human, The Times of London said Thursday.
The experiments will provide researchers with information on diseases such as Parkinson's disease by creating stem cells with the genetic defects responsible for the manifestation of such diseases.
Cytoplasmic embryonic hybrids provide an alternate method to pluripotent stem cell technology that is used to influence the production of genetic variants.
Researchers at King's College said cow eggs are good candidates for research because of their availability and their ability to host the genetic information and stressed the technology only as a scientific tool.
The HFEA licenses include the stipulation that researchers much obtain patient consent forms and approval from ethics committee before working with the human genetic information.
Source: United Press International
Related Articles
- Researchers Identify Phosphorylated Signaling Proteins In Human Embryonic Stem Cells
- FDA Approves Human Embryonic Stem Cell Trial
- Hadassah Hospital Study Shows That Neural Cells Derived From Human Embryonic Stem Cells Reduce Multiple Sclerosis (MS) Symptoms
- Human Embryonic Stem Cells: The Practical Handbook Contains The First Centralised Collection Of Methods Used In Human Embryonic Stem Cell Biology
- Research Indicates Geron's Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack By the Human Immune System
- Stanford Hires Embryonic Stem Cell Research Expert
- Advanced Cell Technology Announces Technique to Generate Human Embryonic Stem Cells That Maintains Developmental Potential of Embryo; Approach Published in Nature
- Researchers Use Human Embryonic Stem Cells to Kill Cancer Cells
- Chemicon International, Inc. Enters into a License to Commercialize Research Products Utilizing Human Embryonic Stem Cell Technology From Wisconsin Alumni Research Foundation (WARF)
- Embryonic Death and the Creation of Human Embryonic Stem Cells
 |
 |
User Comments (0)
RSS Feeds